Literature DB >> 26047667

Experimental models of liver fibrosis.

Sara Crespo Yanguas1, Bruno Cogliati2, Joost Willebrords1, Michaël Maes1, Isabelle Colle3, Bert van den Bossche4, Claudia Pinto Marques Souza de Oliveira5, Wellington Andraus6, Venâncio Avancini Ferreira Alves7, Isabelle Leclercq8, Mathieu Vinken1.   

Abstract

Hepatic fibrosis is a wound healing response to insults and as such affects the entire world population. In industrialized countries, the main causes of liver fibrosis include alcohol abuse, chronic hepatitis virus infection and non-alcoholic steatohepatitis. A central event in liver fibrosis is the activation of hepatic stellate cells, which is triggered by a plethora of signaling pathways. Liver fibrosis can progress into more severe stages, known as cirrhosis, when liver acini are substituted by nodules, and further to hepatocellular carcinoma. Considerable efforts are currently devoted to liver fibrosis research, not only with the goal of further elucidating the molecular mechanisms that drive this disease, but equally in view of establishing effective diagnostic and therapeutic strategies. The present paper provides a state-of-the-art overview of in vivo and in vitro models used in the field of experimental liver fibrosis research.

Entities:  

Keywords:  Animal models; Hepatic stellate cells; In vitro models; Liver fibrosis

Mesh:

Year:  2015        PMID: 26047667      PMCID: PMC4705434          DOI: 10.1007/s00204-015-1543-4

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  235 in total

1.  Large-scale determinants of intestinal schistosomiasis and intermediate host snail distribution across Africa: does climate matter?

Authors:  Anna-Sofie Stensgaard; Jürg Utzinger; Penelope Vounatsou; Eveline Hürlimann; Nadine Schur; Christopher F L Saarnak; Christopher Simoonga; Patricia Mubita; Narcis B Kabatereine; Louis-Albert Tchuem Tchuenté; Carsten Rahbek; Thomas K Kristensen
Journal:  Acta Trop       Date:  2011-11-28       Impact factor: 3.112

2.  A new immortalized rat cell line, hepatic stellate cell-PQ, exhibiting characteristics of hepatic stellate cell.

Authors:  Qin Pan; Ding-Guo Li; Han-Ming Lu; Yu-Qing Wang; Wen-Zhu Zhang; Qin-Fang Xu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-05

Review 3.  Ethanol metabolism, cirrhosis and alcoholism.

Authors:  C S Lieber
Journal:  Clin Chim Acta       Date:  1997-01-03       Impact factor: 3.786

Review 4.  Management of cirrhotic ascites.

Authors:  Julie Steen Pedersen; Flemming Bendtsen; Søren Møller
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

5.  Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.

Authors:  Inge M Westra; Dorenda Oosterhuis; Geny M M Groothuis; Peter Olinga
Journal:  Toxicol Appl Pharmacol       Date:  2013-12-07       Impact factor: 4.219

6.  Ethanol-related liver injury in the rat: a model of steatosis, inflammation and pericentral fibrosis.

Authors:  A Keegan; R Martini; R Batey
Journal:  J Hepatol       Date:  1995-11       Impact factor: 25.083

7.  Significant contribution of liver nonparenchymal cells to metabolism of ammonia and lactate and cocultivation augments the functions of a bioartificial liver.

Authors:  Geir I Nedredal; Kjetil Elvevold; Lars M Ytrebø; Ole-Martin Fuskevåg; Ingvild Pettersen; Kjell Bertheussen; Bodil Langbakk; Bård Smedsrød; Arthur Revhaug
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-03-15       Impact factor: 4.052

8.  Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

9.  Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.

Authors:  Pavel Taimr; Hajime Higuchi; Eva Kocova; Richard A Rippe; Scott Friedman; Gregory J Gores
Journal:  Hepatology       Date:  2003-01       Impact factor: 17.425

10.  Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet.

Authors:  Ayumi Denda; Wakashi Kitayama; Hideki Kishida; Nao Murata; Masahiro Tsutsumi; Toshifumi Tsujiuchi; Dai Nakae; Yoichi Konishi
Journal:  Jpn J Cancer Res       Date:  2002-02
View more
  84 in total

1.  Animal and Human Models of Tissue Repair and Fibrosis: An Introduction.

Authors:  David Lagares; Boris Hinz
Journal:  Methods Mol Biol       Date:  2021

2.  Aldehyde dehydrogenase-2 activation by Alda-1 decreases necrosis and fibrosis after bile duct ligation in mice.

Authors:  Hereward J Wimborne; Kenji Takemoto; Patrick M Woster; Don C Rockey; John J Lemasters; Zhi Zhong
Journal:  Free Radic Biol Med       Date:  2019-09-23       Impact factor: 7.376

Review 3.  Role of xenobiotics in the induction and progression of fatty liver disease.

Authors:  James E Klaunig; Xilin Li; Zemin Wang
Journal:  Toxicol Res (Camb)       Date:  2018-05-18       Impact factor: 3.524

Review 4.  Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Authors:  Nianan Luo; Jiangbin Li; Yu Wei; Jianguo Lu; Rui Dong
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

5.  Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells.

Authors:  Zhen Zhao; Yuanke Li; Akshay Jain; Zhijin Chen; Hao Liu; Wei Jin; Kun Cheng
Journal:  Nanomedicine       Date:  2017-09-07       Impact factor: 5.307

6.  Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors.

Authors:  Assaf Zinger; Lilach Koren; Omer Adir; Maria Poley; Mohammed Alyan; Zvi Yaari; Nadav Noor; Nitzan Krinsky; Assaf Simon; Hadas Gibori; Majd Krayem; Yelena Mumblat; Shira Kasten; Sivan Ofir; Eran Fridman; Neta Milman; Michael M Lübtow; Lior Liba; Jeny Shklover; Janna Shainsky-Roitman; Yoav Binenbaum; Dov Hershkovitz; Ziv Gil; Tal Dvir; Robert Luxenhofer; Ronit Satchi-Fainaro; Avi Schroeder
Journal:  ACS Nano       Date:  2019-09-20       Impact factor: 15.881

7.  Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.

Authors:  Alvi Yasmin; Daniel P Regan; Lawrence B Schook; Ron C Gaba; Kyle M Schachtschneider
Journal:  Biochimie       Date:  2021-01-12       Impact factor: 4.079

8.  Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells.

Authors:  Xiaoping Wu; Lingling Shu; Zixuan Zhang; Jingjing Li; Jiuyu Zong; Lai Yee Cheong; Dewei Ye; Karen S L Lam; Erfei Song; Cunchuan Wang; Aimin Xu; Ruby L C Hoo
Journal:  Adv Sci (Weinh)       Date:  2021-03-27       Impact factor: 16.806

Review 9.  Human Gut Microbiome and Liver Diseases: From Correlation to Causation.

Authors:  Rui Li; Zhengsheng Mao; Xujun Ye; Tao Zuo
Journal:  Microorganisms       Date:  2021-05-08

10.  Smad3 gene C-terminal phosphorylation site mutation exacerbates CCl4-induced hepatic fibrogenesis by promoting pSmad2L/C-mediated signaling transduction.

Authors:  Juan Yang; Yongfang Gong; Wenjing Xu; Lili Li; Zhenghao Shi; Qin Wang; Yinghao He; Chong Zhang; Chenchen Luo; Zhirui Fang; Yan Yang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-06-30       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.